[Elsevier] Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial |
|
This post will be closed automatically in 2026-06-21 10:45
Reward20points
|
post
reply
points
60
10
Real-life outcomes of the PAUL Glaucoma Implant with ripcord in refractory glaucoma
40
Spatiotemporal operation method for mobile virtual power line in power system with mobile energy storage systems
40
Boosting renewable hosting capacity via TCSC-enhanced transmission system planning: P-robust stochastic approach
10
Ultrasound assisted lignin-decorated MWCNT doped flexible PVA每Chitosan composite hydrogel
10
Congenital Laryngomalacia
